PMC10189241_01
Mobilise-D robust patient and public involvement and engagement (PPIE) structures integrated within the overall project governance. Inclusion of the patient voice in the structures of the project ensures accountability and maintains a focus on creating mutual value. The figure summarizes the overall project governance; boards with patient or public representation are highlighted in green/yellow with bold type, external European commission in dark blue, and remaining components in light gray.
dib530413_f02.jpg
PMC10189241_01_dib530413_f02.jpg
F2
Consequently, the consortium established two independent but collaborative governing groups to oversee, plan, and operationalize their PPIE activities: a PPIE Board and a Patient and Public Advisory Group (PPAG; Fig. 2).
PMC10189241_02
Digital measures in the context of the Accelerating Medicines Partnership Schizophrenia (AMP SCZ 72) Program. Digital measures form a key component of gathering a deep phenotype of each patient's lived experience, which is then used to stratify individuals according to their risk profile.
dib530413_f04.jpg
PMC10189241_02_dib530413_f04.jpg
F4
Early detection and intervention before psychosis develops, when individuals are at clinical high risk for psychosis, could attenuate, postpone, or even prevent the transition to psychosis and improve individuals' clinical and functional outcomes (Fig. 4).